Reporting the counterparty's growth as its own: management explains the company's coming year by narrating what its cust
The model's full reasoning — Q1 2024 call → NOWe need to determine if management explains the company's business direction by narrating what its counterparties are doing and scaling. The question asks if a substantial part of the forward account consists of reporting on the growth, expansion, ramp, adoption, or program build-out of specific customers, partners, etc., that the company already supplies or serves, such that the company's own coming volume is a consequence of those parties' trajectories. Looking at the transcript: Management discusses the company's own performance, rig counts, margins, and international expansion. They mention the Middle East awards: seven rigs for a drilling campaign in the Middle East, and an additional rig in Bahrain. They talk about these as part of their international strategy. However, they do not describe the counterparties' own trajectories in detail. They mention "a drilling campaign in the Middle East" but do not narrate the customer's expansion plans, phases, or scaling. They say the rigs are expected to commence operations after delivery, but they don't describe the customer's own growth. They also mention the Saudi Arabia rig award from August 2023. But the focus is on H&P's own actions: converting rigs, exporting, etc. They do not describe the counterparties' business as part of their own. They don't say "our customer is expanding their program" or "they are building out more wells." Instead, they talk about their own contract wins and preparations. The direction of explanation is H&P's own strategy and execution, not the counterparties' growth. Also, they don't provide details on the counterparties' plans. They say "we are not prepared to discuss anything more in detail." So they are not narrating the counterparties' trajectories. The answer is NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| FNV | Franco-Nevada Corporation | Q3 2016 | 2016-11-08 | B+ |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
OOMA · Q3 2022 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future volume as a consequence of those parties' trajectories.
MBLY · Q2 2023 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's volume as a consequence of those parties' trajectories.
ILMN · Q1 2018 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future as a consequence of those parties' trajectories.